PharmChem (PharmChem) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is PharmChem Change In Payables And Accrued Expense?

PharmChem's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was $0.00 Mil. It means PharmChem's Accounts Payable & Accrued Expense stayed the same from Sep. 2022 to Sep. 2023 .

PharmChem's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2002 was $-2.46 Mil. It means PharmChem's Accounts Payable & Accrued Expense declined by $2.46 Mil from Dec. 2001 to Dec. 2002 .

PharmChem Change In Payables And Accrued Expense Historical Data

The historical data trend for PharmChem's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem Change In Payables And Accrued Expense Chart

PharmChem Annual Data

Trend

Dec93

Dec94

Dec95

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.40

0.04

1.63

0.99

-2.46

PharmChem Quarterly Data
	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Sep22	Sep23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.62	0.12	-0.98	-	-

PharmChem Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

PharmChem Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PharmChem's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmChem (PharmChem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PharmChem Inc (OTCPK:PCHM) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2411 E. Loop 820 N, Fort Worth, TX, USA, 76118

Website

https://www.pharmchek.com

PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.

Executives

Alto Investors Palo	10 percent owner	470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp	10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire • 08-11-2021